A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy.

Kausik K RayDavid M KendallZhenxiang ZhaoXiaomei PengA Enrique CaballeroWilliam H PolonskyBeth L NordstromLudi FanBradley H CurtisMelanie Jane Davies

Published in: Diabetes, obesity & metabolism (2019)

Among insulin-treated patients with T2D, treatment changes were common; however, only approximately one-fourth of individuals achieved their HbA1c target.

Keyphrases

type diabetes
glycemic control
stem cells
metabolic syndrome
newly diagnosed